Many common medicines in Australia are not eligible for a new $25 maximum script price under the Pharmaceutical Benefits Scheme, leaving patients with high costs.
In Australia, a variety of common prescription medicines, ranging from ear drops to painkillers, are excluded from the recently introduced $25 maximum script price under the Pharmaceutical Benefits Scheme (PBS). This exemption is causing financial strain for many patients who rely on these essential pharmaceuticals, as they are left to pay full prices for these medications. The pharmaceutical industry has pointed out that in some cases, pharmaceutical companies find it economically unfeasible to apply for subsidies for certain medicines, which contributes to the lack of price control.
